The trademark EXUMA was filed by Exuma Biotech Corp., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 20, 2022, and received one opposition filed on December 20, 2022 by URODA POLSKA Sp. z o.o. on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by SULIMA GRABOWSKA SIERZPUTOWSKA BIURO PATENTÓW I ZNAKÓW TOWAROWYCH SP. Z O.O. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 20, 2022
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on June 8, 2023. Change of name and professional address of the trademark registration was recorded on May 2, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Medicines for human purposes
Biological preparations for medical purposes
Medical biological tissue culture, for the prevention and treatment of cancer drug products
Medical cell inhibitor
Radioactivity drug
Microorganisms (nutritive substances for -)
Nutritional supplements
Medical cell activation drugs
Dressings [medical].
The mark was filed in class 40 with following description of goods:
Custom manufacturing of biological tissue, blood, and cells
Custom manufacturing of pharmaceutical preparations for immunotherapy, including cell therapy
Custom manufacturing of biological preparations for the treatment of cancer.
The mark was filed in class 42 with following description of goods:
Bacteriological research
Biological research
Clinical trials
Medical research
Medical laboratory services
Scientific research
Development of pharmaceutical preparations and drugs